Akums Drugs Pharmaceuticals Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 622.95 as of 12 Jun 15:30 . The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 21.5 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 34.3 on March 2021 to 66 on March 2026 . This represents a CAGR of 11.53% over 6 years The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 7469 crore on March 2025 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 2 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 43002 crore on March 2021 to ₹ 142845 crore on March 2026 . This represents a CAGR of 22.15% over 6 years The revenue of Akums Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 1193 crore as compare to the Dec '25 revenue of ₹ 1193 crore. This represent the decline of -0.06% The revenue of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 4180 crore as compare to the Dec '25 revenue of ₹ 3290 crore. This represent the growth of 27.05% The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 185.23 crore as compare to the Dec '25 ebitda of ₹ 162.96 crore. This represent the growth of 13.67% The ebitda of Torrent Pharmaceuticals Ltd for the Mar '26 is ₹ 1273 crore as compare to the Dec '25 ebitda of ₹ 1065 crore. This represent the growth of 19.53% The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 61.21 crore to ₹ 81.34 crore over 8 quarters. This represents a CAGR of 15.28% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 457 crore to ₹ 364 crore over 8 quarters. This represents a CAGR of -10.75% The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 52.06 % on March 2021 to 58.69 % on March 2026 . This represents a CAGR of 2.02% over 6 years .

About Akums Drugs & Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 9,804 Cr while Market cap of Torrent Pharmaceuticals Ltd is 154,837 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd?

As of June 15, 2026, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹622.95. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹4574.95.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.